咨询电话:021-58952328
SETROBUVIR_CAS号:1071517-39-92017-06-19
产品属性

CAS号:1071517-39-9

重量(克):1g

价格(元):询价

时间:2017-06-19 09:58:01

交易状态:等待报价

产品信息

实单询价

 

化合物简介

Setrobuvir (INN, USAN, also known as ANA-598) was an experimental drug candidate for the treatment of hepatitis C. It was discovered at Anadys Pharmaceuticals. In 2011, Roche acquired Anadys in order to develop setrobuvir. It was in Phase IIb clinical trials, used in combination with interferon and ribavirin, targeting hepatitis C patients with genotype 1.
Setrobuvir works by inhibiting the hepatitis C enzyme NS5B, an RNA polymerase.
Its development was discontinued on July 15, 2015.

基本信息

英文名称:SETROBUVIR
英文别名:Methanesulfonamide,N-(3-((4aR,5S,8R,8aS)-1-((4-fluorophenyl)methyl)-1,2,4a,5,6,7,8,8a-octahydro-4-hydroxy-2-oxo-5,8-methanoquinolin-3-yl)-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl);
N-(3-((1R,2S,7R,8S)-3-((4-fluorophenyl)methyl)-6-hydroxy-4-oxo-3-azatricyclo (6.2.1.02,7)undec-5-en-5-yl)-1,1-dioxo-1,4-dihydro-1lambda6,2,4-benzothiadiazin-7-yl)methanesulfonamide;

ANA-598;

Setrobuvir [USAN];

CAS号:1071517-39-9
分子式:C25H25FN4O6S2
分子量:560.61800
精确质量:560.12000
PSA:162.00000
LogP:4.72520
我要报价
最新产品